Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 3/20 | 0.36 |
| ▸ | THRA | P10827 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 3/20 | 0.35 |
| ▸ | GPR139 | Q6DWJ6 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | ACLY | P53396 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | DDR1 | Q08345 | 1/20 | 0.32 |
| ▸ | PDE5A | O76074 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4927472 | 0.92 | SMN1; SMN2 (0.36) | SMN1; SMN2MAPTRAB9AL3MBTL1THRB | |
| SCHEMBL4947897 | 0.91 | KMT2A (0.39) | SMN1; SMN2MAPTRAB9ALMNAGPR139 | |
| SCHEMBL4929941 | 0.90 | SMN1; SMN2 (0.38) | SMN1; SMN2MAPTRAB9AL3MBTL1THRB | |
| SCHEMBL4348405 | 0.90 | SMN1; SMN2 (0.39) | SMN1; SMN2MAPTRAB9AL3MBTL1THRB | |
| SCHEMBL4922427 | 0.90 | SMN1; SMN2 (0.36) | SMN1; SMN2MAPTRAB9AL3MBTL1THRB | |
| SCHEMBL4934502 | 0.89 | GPR139 (0.37) | SMN1; SMN2MAPTRAB9AL3MBTL1THRB | |
| SCHEMBL5104287 | 0.88 | THRA (0.37) | SMN1; SMN2MAPTRAB9AL3MBTL1THRB | |
| SCHEMBL5104790 | 0.88 | BRD4 (0.36) | SMN1; SMN2MAPTRAB9AL3MBTL1THRB | |
| SCHEMBL5103319 | 0.87 | ACLY (0.37) | SMN1; SMN2MAPTRAB9AL3MBTL1LMNA | |
| SCHEMBL4934616 | 0.87 | CACNA1I (0.35) | ACLY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080221210-A1 | Thyroid Receptor Agonists | KARO BIO AB (SE) | 2008-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221210-A1 | Thyroid Receptor Agonists | TSHR, TRHR, THRA | SMN1; SMN2 4282/4885MAPT 4142/4885RAB9A 986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.